The Veterans for Cannabis Foundation has partnered with Medicinal Genomics and Courtagen Life Sciences to help develop brand and strain names that may be more palatable to potential government committees allowing cannabis data to, perhaps, get a fair review.
Under the co-promotion agreement, Medicinal Genomics will provide StrainSEEK, a strain identification and registration service, to the VFCF. The service will track CBD products created specifically for the foundation which will be available to VFCF members at a discount. The strains are designed to treat chronic pain, post-traumatic stress disorder, and neurological conditions.
“[The VFCF] mission of effecting change through data collection may ultimately help to reduce the unnecessary deaths amongst our veteran population, in particular for conditions where opioids are commonly prescribed.” Mike Catalano, head of marketing for Medicinal Genomics and Courtagen said in a press release. “Registering the genetic fingerprint of the cannabis strains used will help control the consistency of the products and the data collection efforts.”
By tracking the genetics, the original names of the strains will not be lost.
Joshua Littrell, founder of VFCF, said the StrainSEEK program helps the organization “take some of the guess work” out of cannabis treatments for veterans.
“VFCF will now be able to replicate and reproduce the experience for veterans in our program. Our veterans are begging for a treatment they can trust and that is uniform,” he said in the release. “Now they can rest assured knowing they are receiving the same treatment every time.”